The receptor repertoire defines the host range for attaching Escherichia coli strains that recognize globo-A.
Escherichia coli strains which colonize the human urinary tract express lectins specific for different members of the globoseries of glycolipids, e.g., globotetraosylceramide and globo-A. This study investigated the importance of globo-A expression for attachment to human uroepithelial cells, colonization of the urinary tract, and severity of urinary tract infection. The expression of receptor-active glycolipids by erythrocytes and epithelial cells was analyzed by thin-layer chromatography and bacterial overlay as well as by bacterial binding to those cells. The epithelial expression of the globo-A receptor was restricted to individuals of blood group A with a positive secretor state. Consequently, globo-A binding E. coli strains attached only to epithelial cells from these individuals. In contrast, globoside-recognizing strains attached in similar numbers to uroepithelial cells regardless of the ABH blood group and secretor state of the donor. The role of host receptor expression for infection with globo-A-specific E. coli was analyzed in 1,473 children with urinary tract infections. All those infected with strains exclusively expressing globo-A-specific adhesins were found to be of blood group A, compared with 45% in the population at large (P less than 0.006). The inflammatory response (fever, C-reactive protein, erythrocyte sedimentation rate) of individuals infected with these strains was lower than that in individuals with infections caused by globoside binding strains. The results demonstrate the importance of fitness between host receptors and bacterial adhesins for infection and suggest that minor receptor epitope differences have profound effects on the disease process.
Lindstedt
R
R
Department of Clinical Immunology, Lund University, Sweden.
Larson
G
G
Falk
P
P
Jodal
U
U
Leffler
H
H
Svanborg
C
C
D000017:ABO Blood-Group System; D018830:Adhesins, Escherichia coli; D001422:Bacterial Adhesion; D001425:Bacterial Outer Membrane Proteins / Q000378:metabolism; D002240:Carbohydrate Sequence; D002675:Child, Preschool; D002855:Chromatography, Thin Layer; D004198:Disease Susceptibility; D004848:Epithelium / Q000378:metabolism / Q000382:microbiology; D004912:Erythrocytes / Q000378:metabolism; D004926:Escherichia coli / Q000378:metabolism* / Q000472:pathogenicity; D005260:Female; D005915:Globosides / Q000378:metabolism*; D006001:Glycoconjugates / Q000378:metabolism; D006017:Glycolipids / Q000378:metabolism; D006801:Humans; D007223:Infant; D007249:Inflammation / Q000209:etiology; D008297:Male; D008969:Molecular Sequence Data; D009092:Mucous Membrane / Q000378:metabolism / Q000382:microbiology; D011956:Receptors, Cell Surface; D011971:Receptors, Immunologic / Q000378:metabolism*; D014551:Urinary Tract / Q000378:metabolism / Q000382:microbiology; D014552:Urinary Tract Infections / Q000097:blood / Q000276:immunology / Q000382:microbiology
D000017:ABO Blood-Group System; D018830:Adhesins, Escherichia coli; D001425:Bacterial Outer Membrane Proteins; D005915:Globosides; D006001:Glycoconjugates; D006017:Glycolipids; D011956:Receptors, Cell Surface; D011971:Receptors, Immunologic; C033639:glycolipid receptor